Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Huntington Disease | 21 | 2023 | 1111 | 3.370 |
Why?
|
Tetrabenazine | 8 | 2022 | 18 | 3.150 |
Why?
|
Adrenergic Uptake Inhibitors | 6 | 2019 | 189 | 2.330 |
Why?
|
Chorea | 5 | 2022 | 74 | 1.930 |
Why?
|
Labyrinth Diseases | 2 | 2018 | 150 | 1.090 |
Why?
|
Vertigo | 2 | 2018 | 201 | 1.070 |
Why?
|
Parkinson Disease | 16 | 2019 | 2774 | 0.900 |
Why?
|
Tremor | 3 | 2020 | 174 | 0.840 |
Why?
|
Neurology | 4 | 2007 | 762 | 0.570 |
Why?
|
Spinocerebellar Degenerations | 1 | 2015 | 43 | 0.540 |
Why?
|
Drug Substitution | 1 | 2017 | 281 | 0.500 |
Why?
|
Ataxia | 1 | 2015 | 304 | 0.450 |
Why?
|
Education, Medical, Graduate | 3 | 2012 | 2283 | 0.440 |
Why?
|
Publication Bias | 1 | 2011 | 161 | 0.380 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 854 | 0.380 |
Why?
|
Research Subjects | 5 | 2014 | 238 | 0.380 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2017 | 770 | 0.370 |
Why?
|
Brain Tissue Transplantation | 2 | 2007 | 81 | 0.360 |
Why?
|
Writing | 1 | 2012 | 205 | 0.360 |
Why?
|
Peer Review, Research | 1 | 2012 | 329 | 0.330 |
Why?
|
Teaching | 2 | 2007 | 1174 | 0.310 |
Why?
|
Fetal Stem Cells | 1 | 2007 | 10 | 0.310 |
Why?
|
Ethics, Clinical | 1 | 2008 | 99 | 0.300 |
Why?
|
Data Collection | 2 | 2014 | 3339 | 0.290 |
Why?
|
Internship and Residency | 4 | 2012 | 5774 | 0.290 |
Why?
|
Editorial Policies | 1 | 2011 | 451 | 0.290 |
Why?
|
Conflict of Interest | 1 | 2011 | 542 | 0.280 |
Why?
|
Athetosis | 1 | 2005 | 16 | 0.280 |
Why?
|
Neurosurgical Procedures | 3 | 2008 | 2002 | 0.270 |
Why?
|
Disclosure | 1 | 2011 | 736 | 0.260 |
Why?
|
Placebos | 2 | 2008 | 1677 | 0.250 |
Why?
|
Withholding Treatment | 1 | 2008 | 598 | 0.230 |
Why?
|
Self Report | 1 | 2014 | 3548 | 0.230 |
Why?
|
Neuroprotective Agents | 1 | 2010 | 941 | 0.230 |
Why?
|
Hospital Departments | 1 | 2003 | 137 | 0.220 |
Why?
|
Therapeutic Misconception | 2 | 2014 | 8 | 0.210 |
Why?
|
Spinal Injuries | 1 | 2005 | 301 | 0.210 |
Why?
|
Double-Blind Method | 6 | 2022 | 12017 | 0.190 |
Why?
|
Stem Cell Transplantation | 2 | 2007 | 1618 | 0.190 |
Why?
|
Torticollis | 1 | 2021 | 66 | 0.190 |
Why?
|
Corpus Striatum | 1 | 2007 | 1220 | 0.190 |
Why?
|
Periodicals as Topic | 1 | 2012 | 1431 | 0.190 |
Why?
|
Problem-Based Learning | 1 | 2004 | 359 | 0.190 |
Why?
|
Dystonia | 2 | 2020 | 363 | 0.180 |
Why?
|
Risk Management | 1 | 2003 | 571 | 0.170 |
Why?
|
Dopamine Agents | 1 | 2019 | 189 | 0.160 |
Why?
|
Disease Progression | 4 | 2019 | 13256 | 0.160 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15530 | 0.160 |
Why?
|
Psychometrics | 2 | 2017 | 2999 | 0.150 |
Why?
|
Australia | 2 | 2017 | 1167 | 0.150 |
Why?
|
Physician's Role | 1 | 2004 | 942 | 0.150 |
Why?
|
Humans | 51 | 2023 | 742088 | 0.150 |
Why?
|
Dementia | 1 | 2011 | 2501 | 0.150 |
Why?
|
Gait Disorders, Neurologic | 1 | 2019 | 230 | 0.150 |
Why?
|
Treatment Outcome | 9 | 2022 | 62966 | 0.150 |
Why?
|
Spinal Puncture | 1 | 2019 | 281 | 0.140 |
Why?
|
Antipsychotic Agents | 1 | 2010 | 3058 | 0.140 |
Why?
|
Electroencephalography | 1 | 2011 | 6142 | 0.140 |
Why?
|
Dystonic Disorders | 1 | 2019 | 329 | 0.130 |
Why?
|
Ubiquinone | 1 | 2016 | 188 | 0.130 |
Why?
|
Internationality | 1 | 2020 | 1002 | 0.130 |
Why?
|
Middle Aged | 29 | 2021 | 213127 | 0.130 |
Why?
|
Medical Errors | 1 | 2003 | 1296 | 0.120 |
Why?
|
Quality of Life | 4 | 2023 | 12730 | 0.120 |
Why?
|
Trinucleotide Repeats | 2 | 2012 | 261 | 0.120 |
Why?
|
Bell Palsy | 1 | 2014 | 42 | 0.120 |
Why?
|
Drug Interactions | 1 | 2019 | 1458 | 0.120 |
Why?
|
Antiparkinson Agents | 1 | 2014 | 183 | 0.120 |
Why?
|
Saliva | 1 | 2017 | 805 | 0.110 |
Why?
|
Anti-Dyskinesia Agents | 1 | 2013 | 25 | 0.110 |
Why?
|
Pharynx | 1 | 2015 | 413 | 0.110 |
Why?
|
Male | 31 | 2021 | 349538 | 0.110 |
Why?
|
Football | 1 | 2018 | 460 | 0.110 |
Why?
|
Receptors, Kainic Acid | 1 | 2012 | 88 | 0.110 |
Why?
|
Receptors, Dopamine | 1 | 2013 | 294 | 0.110 |
Why?
|
Codon, Terminator | 1 | 2012 | 127 | 0.100 |
Why?
|
Aged | 18 | 2021 | 162944 | 0.100 |
Why?
|
Muscle Spasticity | 1 | 2013 | 154 | 0.100 |
Why?
|
tau Proteins | 2 | 2018 | 1860 | 0.100 |
Why?
|
Sensation Disorders | 2 | 2017 | 156 | 0.100 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2012 | 374 | 0.100 |
Why?
|
Botulinum Toxins | 1 | 2013 | 192 | 0.100 |
Why?
|
Informed Consent | 3 | 2013 | 991 | 0.100 |
Why?
|
International Classification of Diseases | 1 | 2014 | 865 | 0.090 |
Why?
|
Motivation | 3 | 2014 | 1968 | 0.080 |
Why?
|
Research Personnel | 1 | 2014 | 573 | 0.080 |
Why?
|
Female | 27 | 2021 | 379592 | 0.080 |
Why?
|
Amyloid beta-Peptides | 2 | 2018 | 3574 | 0.080 |
Why?
|
Consent Forms | 1 | 2008 | 53 | 0.080 |
Why?
|
Drug Evaluation | 1 | 2009 | 637 | 0.080 |
Why?
|
Heat-Shock Proteins | 1 | 2012 | 822 | 0.080 |
Why?
|
Vitamins | 1 | 2016 | 1608 | 0.080 |
Why?
|
Ethics, Research | 2 | 2009 | 190 | 0.080 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 895 | 0.080 |
Why?
|
Health Literacy | 1 | 2013 | 414 | 0.070 |
Why?
|
Membrane Glycoproteins | 1 | 2018 | 3769 | 0.070 |
Why?
|
Gene Transfer Techniques | 2 | 2009 | 1224 | 0.070 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2008 | 319 | 0.070 |
Why?
|
Ethics Committees, Research | 1 | 2008 | 194 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2014 | 7901 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3461 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39004 | 0.070 |
Why?
|
Therapeutic Human Experimentation | 1 | 2005 | 42 | 0.070 |
Why?
|
Age of Onset | 4 | 2013 | 3266 | 0.070 |
Why?
|
United States | 7 | 2017 | 69693 | 0.070 |
Why?
|
Time | 1 | 2007 | 530 | 0.070 |
Why?
|
Polymorphism, Genetic | 2 | 2013 | 4328 | 0.070 |
Why?
|
Neurosurgery | 1 | 2012 | 642 | 0.070 |
Why?
|
Alcoholism | 1 | 2015 | 1904 | 0.060 |
Why?
|
Placebo Effect | 2 | 2005 | 502 | 0.060 |
Why?
|
Longitudinal Studies | 4 | 2023 | 13921 | 0.060 |
Why?
|
Proprioception | 1 | 2005 | 132 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2013 | 9941 | 0.060 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 12220 | 0.060 |
Why?
|
Single-Blind Method | 1 | 2008 | 1589 | 0.060 |
Why?
|
Decision Making | 3 | 2013 | 3869 | 0.060 |
Why?
|
Trust | 1 | 2008 | 501 | 0.060 |
Why?
|
Periodicity | 1 | 2004 | 363 | 0.060 |
Why?
|
Demography | 1 | 2008 | 1650 | 0.050 |
Why?
|
Attitude to Health | 1 | 2012 | 2051 | 0.050 |
Why?
|
Adult | 14 | 2021 | 213712 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2009 | 1827 | 0.050 |
Why?
|
Affective Symptoms | 1 | 2004 | 407 | 0.050 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2021 | 34 | 0.050 |
Why?
|
Perception | 1 | 2008 | 1188 | 0.050 |
Why?
|
Crohn Disease | 1 | 2014 | 2301 | 0.050 |
Why?
|
Treatment Failure | 1 | 2007 | 2615 | 0.050 |
Why?
|
Professional Competence | 1 | 2004 | 448 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2021 | 15494 | 0.050 |
Why?
|
Electromyography | 1 | 2005 | 1391 | 0.050 |
Why?
|
Patient Participation | 1 | 2009 | 1445 | 0.050 |
Why?
|
Muscle Rigidity | 1 | 2019 | 35 | 0.040 |
Why?
|
Young Adult | 5 | 2020 | 56350 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3731 | 0.040 |
Why?
|
Anxiety | 2 | 2023 | 4279 | 0.040 |
Why?
|
Clinical Clerkship | 1 | 2004 | 531 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57683 | 0.040 |
Why?
|
Post-Dural Puncture Headache | 1 | 2019 | 48 | 0.040 |
Why?
|
Comprehension | 2 | 2014 | 608 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3611 | 0.040 |
Why?
|
Cohort Studies | 5 | 2020 | 40450 | 0.040 |
Why?
|
Medical Records | 1 | 2003 | 1413 | 0.040 |
Why?
|
Pain | 1 | 2013 | 4961 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2021 | 581 | 0.040 |
Why?
|
Research Design | 3 | 2012 | 5979 | 0.040 |
Why?
|
Medication Errors | 1 | 2003 | 797 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2019 | 975 | 0.040 |
Why?
|
Medicare | 1 | 2014 | 6532 | 0.040 |
Why?
|
Graft Survival | 1 | 2007 | 3733 | 0.040 |
Why?
|
Tinnitus | 1 | 2019 | 195 | 0.030 |
Why?
|
Biomedical Research | 1 | 2012 | 3306 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2021 | 19862 | 0.030 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2016 | 106 | 0.030 |
Why?
|
Gene Frequency | 1 | 2021 | 3587 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2018 | 748 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1705 | 0.030 |
Why?
|
Memory | 1 | 2023 | 2163 | 0.030 |
Why?
|
Movement Disorders | 1 | 2017 | 444 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 24913 | 0.030 |
Why?
|
Postural Balance | 1 | 2017 | 620 | 0.030 |
Why?
|
Time Factors | 2 | 2017 | 40054 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2003 | 2749 | 0.030 |
Why?
|
Receptors, Dopamine D4 | 1 | 2013 | 171 | 0.030 |
Why?
|
Transcription Factors | 1 | 2012 | 12164 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1423 | 0.030 |
Why?
|
Founder Effect | 1 | 2012 | 190 | 0.020 |
Why?
|
alpha-Synuclein | 1 | 2017 | 724 | 0.020 |
Why?
|
Canada | 1 | 2016 | 2061 | 0.020 |
Why?
|
Catechol O-Methyltransferase | 1 | 2013 | 245 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2019 | 1895 | 0.020 |
Why?
|
Herpes Simplex | 1 | 2014 | 466 | 0.020 |
Why?
|
Biological Specimen Banks | 1 | 2016 | 707 | 0.020 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2012 | 242 | 0.020 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2013 | 422 | 0.020 |
Why?
|
Alleles | 2 | 2012 | 6931 | 0.020 |
Why?
|
Receptors, Dopamine D2 | 1 | 2013 | 475 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2012 | 508 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2023 | 6974 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1421 | 0.020 |
Why?
|
Microglia | 1 | 2018 | 1261 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2007 | 11470 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5062 | 0.020 |
Why?
|
Brain | 1 | 2015 | 26343 | 0.020 |
Why?
|
Risk Assessment | 2 | 2012 | 23320 | 0.020 |
Why?
|
Clinical Competence | 1 | 2004 | 4681 | 0.020 |
Why?
|
Adolescent | 4 | 2020 | 85649 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2425 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4929 | 0.020 |
Why?
|
Methotrexate | 1 | 2014 | 1720 | 0.020 |
Why?
|
Attitude | 1 | 2012 | 772 | 0.020 |
Why?
|
Genetics, Population | 1 | 2012 | 933 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2014 | 2536 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3339 | 0.020 |
Why?
|
Qualitative Research | 1 | 2014 | 2680 | 0.020 |
Why?
|
Haplotypes | 1 | 2012 | 2781 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2017 | 5095 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2007 | 15244 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2699 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2013 | 1914 | 0.010 |
Why?
|
Self-Assessment | 1 | 2004 | 390 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8333 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2017 | 4030 | 0.010 |
Why?
|
Neural Pathways | 1 | 2013 | 2971 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12344 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16331 | 0.010 |
Why?
|
Child, Preschool | 2 | 2015 | 40955 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4147 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7716 | 0.010 |
Why?
|
Seizures | 1 | 2013 | 2851 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17400 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4465 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 35342 | 0.010 |
Why?
|
Animals | 1 | 2010 | 168561 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4982 | 0.010 |
Why?
|
Pilot Projects | 1 | 2009 | 8297 | 0.010 |
Why?
|
Child | 2 | 2015 | 77478 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 3915 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2004 | 6030 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 21719 | 0.010 |
Why?
|
Infant | 1 | 2015 | 35070 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2016 | 77098 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 29717 | 0.000 |
Why?
|
Concepts
(222)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_